SASKATOON, Saskatchewan–(BUSINESS WIRE)– #HealthcareInnovations–ZYUS Life Sciences Corporation (the “Company”) (TSX-V: ZYUS), a Canadian-based life sciences company leading scientific research and global development of innovative cannabinoid-based pharmaceutical drug products, today announced the appointment of Hance Clarke, MD, PhD, FRCPC to ZYUS Life Sciences Inc.’s Clinical Advisory Committee. Dr. Clarke’s extensive background in healthcare and pain management aligns seamlessly with the committee’s mission to pro
- SEO Powered Content & PR Distribution. Get Amplified Today.
- PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
- PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
- PlatoESG. Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
- PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
- Source: https://mmpconnect.com/zyus-strengthens-expertise-of-clinical-advisory-committee-with-the-appointment-of-dr-hance-clarke/?utm_source=rss&utm_medium=rss&utm_campaign=zyus-strengthens-expertise-of-clinical-advisory-committee-with-the-appointment-of-dr-hance-clarke
- a
- advisory
- Aligns
- and
- announced
- appointment
- background
- business
- Business Wire
- Clinical
- committee
- company
- connection
- CORPORATION
- CSS
- Development
- dr
- drug
- expertise
- extensive
- Global
- healthcare
- http
- HTTPS
- in
- innovative
- jpg
- leading
- Life
- Life Sciences
- LINK
- management
- marijuana
- medical
- Medical Marijuana
- Mission
- of
- Pain
- Pain Management
- Pharmaceutical
- phd
- plato
- Plato Data Intelligence
- PlatoData
- Products
- Program
- research
- SCIENCES
- scientific
- Scientific Research
- seamlessly
- Strengthens
- The
- to
- today
- Wire
- with
- zephyrnet